Evaluation of expression of Toll-Like Receptors 7 and 9, proliferation, and cytoskeletal biomarkers in plaque and guttate psoriasis: A pilot morphological study

Submitted: 11 January 2021
Accepted: 18 February 2021
Published: 5 March 2021
Abstract Views: 642
PDF: 410
HTML: 11
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

This pilot study was aimed at comparing TLR7/TLR9 expression, cytoskeletal arrangement, and cell proliferation by indirect immunofluorescence in parallel lesional and non lesional skin samples of guttate psoriasis (PG) and psoriasis vulgaris (PV) in five male patients for each group (n=10). TLR7 expression was detected throughout all the epidermal compartment in PV samples, while in PG skin was restricted to the granular layer. TLR9 was present in the granular layer of non lesional skin and in the suprabasal layers of PV/PG lesional skin. Cell proliferation was localized in all the epidermal layers in lesional PG and PV, consistently with the immunopositivity for the “psoriatic keratin” K16. In the suprabasal layers of lesional PG and PV skin, a similar K17 expression was detected and K10 exhibited a patchy distribution. The present results suggest that TLR7 expression can be considered an intrinsic and differential histomorphological feature of PV.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Nestle FO, Kaplan DH, Barker J.Mechanisms of disease: psoriasis. N Engl J Med 2009;361:496-509. DOI: https://doi.org/10.1056/NEJMra0804595
Lebwohl M. Psoriasis. Lancet 2003;361:1197-204. DOI: https://doi.org/10.1016/S0140-6736(03)12954-6
Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol 2014;32:227-55. DOI: https://doi.org/10.1146/annurev-immunol-032713-120225
Takahashi T, Gallo RL. The critical and multifunctional roles of antimicrobial peptides in dermatology. Dermatol Clin 2017;35:39-50. DOI: https://doi.org/10.1016/j.det.2016.07.006
Fuentes-Duculan J, Bonifacio KM, Hawkes JE, Kunjravia N, Cueto I, Li X, et al. Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active psoriasis and localized with keratinocytes, dendritic cells and other leukocytes. Exp Dermatol 2017;26:1075-82. DOI: https://doi.org/10.1111/exd.13378
Girolomoni G, Mrowietz U, Paul C. Psoriasis: rationale for targeting interleukin-17. Br J Dermatol 2012;167:717-24. DOI: https://doi.org/10.1111/j.1365-2133.2012.11099.x
Miller LS. Toll-like receptors in skin. Adv Dermatol 2008;24:71-87. DOI: https://doi.org/10.1016/j.yadr.2008.09.004
Hari A, Flach TL, Shi Y, Mydlarski PR. Toll-like receptors: role in dermatological disease. Mediators Inflamm 2010;2010: 437246. DOI: https://doi.org/10.1155/2010/437246
Gilliet M, Conrad C, Geiges M, Cozzio A, Thürlimann W, Burg G, et al. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 2004;140:1490-5. DOI: https://doi.org/10.1001/archderm.140.12.1490
Morizane S, Yamasaki K, Mühleisen B, Kotol PF, Murakami M, Aoyama Y, et al. Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. J Invest Dermatol 2012;132:135-43. DOI: https://doi.org/10.1038/jid.2011.259
Donetti E, Cornaghi L, Arnaboldi F, Ricceri F, Pescitelli L, Maiocchi M, et al. Epidermal barrier reaction to an in vitro psoriatic microenvironment. Exp Cell Res 2017;360:180-8. DOI: https://doi.org/10.1016/j.yexcr.2017.09.004
Karantza V. Keratins in health and cancer: more than mere epithelial cell markers. Oncogene 2011;30:127-38. DOI: https://doi.org/10.1038/onc.2010.456
Donetti E, Lombardo G, Baruffaldi Preis FW, Cornaghi L, Pescitelli L, Prignano F. 3D skin model to investigate the early epidermal morphological psoriatic features. J Transl Sci 2019;6:1-4.
Bedoni M, Sforza C, Dolci C, Donetti E. Proliferation and differentiation biomarkers in normal human breast skin organotypic cultures. J Dermatol Sci 2007;46:139-42. DOI: https://doi.org/10.1016/j.jdermsci.2006.12.005
El Tawdy AM, Amin IM, Abdel Hay RM, Hassan AS, Gad, ZS, Rashed LA. Toll-like receptor (TLR)7 expression in mycosis fungoides and psoriasis: a case–control study. Clin Exp Dermatol 2017;42:172-7. DOI: https://doi.org/10.1111/ced.13008
Kim HJ, Kim SH, Je JH, Shin DY, Kim DS, Lee MG. Increased expression of Toll-like receptors 3, 7, 8 and 9 in peripheral blood mononuclear cells in pastients with psoriasis. Exp Dermatol 2016;25:485-7. DOI: https://doi.org/10.1111/exd.12974
Gürel G, Sabah-Özcan S. Evaluation of Toll-like receptor expression profile in patients with psoriasis vulgaris. Gene 2019;702:166-70. DOI: https://doi.org/10.1016/j.gene.2019.03.058
Seung NR, Park EJ, Kim CW, Kim KH, Kim KJ, Cho HJ, et al. Comparison of expression of heat-shock protein 60, Toll-like receptors 2 and 4, and T-cell receptor γδ in plaque and guttate psoriasis. J Cutan Pathol 2007;34:903-11. DOI: https://doi.org/10.1111/j.1600-0560.2007.00756.x
Shi X, Jin L, Dang E, Chang T, Feng Z, Liu Y, et al. IL-17A upregulates keratin 17 expression in keratinocytes through STAT1-and STAT3-dependent mechanisms. J Invest Dermatol 2011;131:2401-8. DOI: https://doi.org/10.1038/jid.2011.222
Zhang W, Dang E, Shi X, Jin L, Feng Z, Hu L, et al. The pro-inflammatory cytokine il-22 up-regulates keratin 17 expression in keratinocytes via STAT3 and ERK1/2. PLoS One 2012;7:e40797. DOI: https://doi.org/10.1371/journal.pone.0040797
Shen Z, Chen L, Liu YF, Gao TW, Wang G, Fan XL, et al. Altered keratin 17 peptide ligands inhibit in vitro proliferation of keratinocytes and T cells isolated from patients with psoriasis. J Am Acad Dermatol 2006;5:992-1002. DOI: https://doi.org/10.1016/j.jaad.2006.02.033
Yang L, Zhang S, Wang G. Keratin 17 in disease pathogenesis: from cancer to dermatoses. J Pathol 2019;247:158-65.
Mussari CP, Dodd DS, Sreekantha RK, Pasunoori L, Wan H, Posy SL, et al. Discovery of potent and orally bioavailable small molecule antagonists of Toll-like receptors 7/8/9 (TLR7/8/9). ACS Med Chem Lett 2020;11:1751-8. DOI: https://doi.org/10.1021/acsmedchemlett.0c00264
Patinote C, Karroum NB, Moarbess G, Cirnat N, Kassab I, Bonnet PA, et al. Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes. Eur J Med Chem 2020;193:112238. DOI: https://doi.org/10.1016/j.ejmech.2020.112238

How to Cite

Prignano, F., Lombardo, G., Indino, S., Ricceri, F., Cornaghi, L., & Donetti, E. B. (2021). Evaluation of expression of Toll-Like Receptors 7 and 9, proliferation, and cytoskeletal biomarkers in plaque and guttate psoriasis: A pilot morphological study. European Journal of Histochemistry, 65(1). https://doi.org/10.4081/ejh.2021.3218